A patient with a recent diagnosis of chronic myelogenous leukemia (CML) is discussing treatment options with his care team. What aspect of the patient's condition would contraindicate the use of cyclophosphamide for the treatment of leukemia?
A) The patient has a diagnosis of type 2 diabetes and takes oral antihyperglycemics.
B) The patient has had a history of nonadherence to medical treatment.
C) The patient's bone marrow function is significantly depressed.
D) The patient has decreased renal function.
Question 2
A 54-year-old received a diagnosis of breast cancer several weeks ago and her current treatment regimen includes tamoxifen, a cell cyclenonspecific antineoplastic drug.
Which of the following is a characteristic of a cell cyclenonspecific drug?
A) The drug is effective regardless of whether a cancerous cell is proliferating.
B) The drug is capable of inducing cell division and subsequent mutations of cancerous cells.
C) The drug is readily able to distinguish between normal body cells and malignant cells.
D) The drug induces an abnormal cell cycle that results in cancerous cell death.
EHR systems enable providers to view patient records across organizations.
Reputable Websites for Patient Education
A pacemaker in a patient’s chest.
IgG after treatment with pepsin.
Dental Related Adverse Effects in Patients Undergoing Cancer Treatment